Photo collage: Brock E.W. Turner/Axios. Photo: Courtesy of General Medicine
TJ Parker is stepping back as a general partner at venture capital firm Matrix after over three years with the firm.
What's next: The former CEO of PillPack — sold to Amazon for roughly $1 billion in cash in 2019 — is pursuing another pharmacy-heavy health care storefront.
Parker will remain a Matrix venture partner and stay on the boards of Headlight, Optura, Mevo, Taxa, and Metriport.
However, his main focus will be at General Medicine as CEO.
